Apatinib preferentially inhibits PC9 gefitinib-resistant cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway. [electronic resource]

By: Contributor(s): Publication details: Cancer cell international 2019Description: 117 p. digitalISSN:
  • 1475-2867
Online resources: In: Cancer cell international vol. 19
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.